Gene · 7409
Papers3,486
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,486
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities. | Cells | 2023 | 38201290 | PubTator, text mining | PubMed |
| [ARL67156, a small-molecule CD39 inhibitor, enhances natural killer cell cytotoxicity against gastric cancer cells in vitro and in nude mice]. | Nan Fang Yi Ke Da Xue Xue Bao | 2023 | 38189385 | PubTator, text mining | PubMed |
| Bioinformatic analysis reveals the clinical value of SASH3 in survival prognosis and immune infiltration of acute myelocytic leukemia (AML). | Am J Transl Res | 2023 | 38186980 | PubTator, text mining | PubMed |
| Identification of the Axis β-Catenin-BTK in the Dynamic Adhesion of Chronic Lymphocytic Leukemia Cells to Their Microenvironment. | Int J Mol Sci | 2023 | 38139452 | PubTator, text mining | PubMed |
| The Role of NKG2D and Its Ligands in Autoimmune Diseases: New Targets for Immunotherapy. | Int J Mol Sci | 2023 | 38139373 | PubTator, text mining | PubMed |
| CD6 and Its Interacting Partners: Newcomers to the Block of Cancer Immunotherapies. | Int J Mol Sci | 2023 | 38139340 | PubTator, text mining | PubMed |
| Plasma Levels of mir-34a-5p Correlate with Systemic Inflammation and Low Naïve CD4 T Cells in Common Variable Immunodeficiency. | J Clin Immunol | 2023 | 38129593 | PubTator, text mining | PubMed |
| Exploring the interaction between extracellular matrix components in a 3D organoid disease model to replicate the pathophysiology of breast cancer. | J Exp Clin Cancer Res | 2023 | 38102637 | PubTator, text mining | PubMed |
| Killer instincts: natural killer cells as multifactorial cancer immunotherapy. | Front Immunol | 2023 | 38090565 | PubTator, text mining | PubMed |
| The role of carcinoembryonic antigen-related cell adhesion molecule 1 in cancer. | Front Immunol | 2023 | 38077351 | PubTator, text mining | PubMed |
| The Rac-GEF Tiam1 controls integrin-dependent neutrophil responses. | Front Immunol | 2023 | 38077328 | PubTator, text mining | PubMed |
| Clonal hematopoiesis related TET2 loss-of-function impedes IL1β-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells. | Nat Commun | 2023 | 38062031 | PubTator, text mining | PubMed |
| Refractory Status Epilepticus Associated With a Pathogenic Variant in TNFRSF13B. | Cureus | 2023 | 38054159 | PubTator, text mining | PubMed |
| Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy. | MedComm (2020) | 2023 | 38045827 | PubTator, text mining | PubMed |
| Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions. | Haematologica | 2023 | 38037800 | PubTator, text mining | PubMed |
| Role of the redox state of the Pirin-bound cofactor on interaction with the master regulators of inflammation and other pathways. | PLoS One | 2023 | 38033031 | PubTator, text mining | PubMed |
| Progression of adult T-cell leukemia/lymphoma from smoldering to acute type due to branched subclonal evolution. | EJHaem | 2023 | 38024629 | PubTator, text mining | PubMed |
| Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurines. | Ann Gastroenterol | 2023 | 38023976 | PubTator, text mining | PubMed |
| The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas. | Front Oncol | 2023 | 38023160 | PubTator, text mining | PubMed |
| Small molecule inhibitors for cancer immunotherapy and associated biomarkers - the current status. | Front Immunol | 2023 | 38022587 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7409/papers?page=6